AXERT 12.5MG
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is AXERT 12.5MG discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that AXERT 12.5MG has been permanently discontinued (last updated October 28, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is AXERT 12.5MG not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
SANDOZ ALMOTRIPTAN
SANDOZ CANADA INCORPORATED
JAMP ALMOTRIPTAN
JAMP PHARMA CORPORATION
ALMOTRIPTAN
SANIS HEALTH INC
PMS-ALMOTRIPTAN
PHARMASCIENCE INC
Other Products
AG-ALMOTRIPTAN
ANGITA PHARMA INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02248129
Strength
12.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ALMOTRIPTAN
Tier
Unrated
Last Updated
2017-10-28
Reason for Shortage
Business reasons
Other Products from MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.